Efficacy and Safety of Neoadjuvant Subcutaneous Envafolimab in dMMR/MSI-H Locally Advanced Colon Cancer.

Yuan LiWeili ZhangJie DuJinlong HuRuixi HuZiyang ZengE-Er-Man-Bie-Ke Jin-Si-HanShaopu LianHao WangYunfeng LiZhizhong PanCheng FengXuan ZhangZhen-Hai Lu

Published in: Targeted oncology (2024)

Envafolimab yielded promising surgical outcomes and safety in dMMR/MSI-H locally advanced colon cancer, representing a promising treatment modality for this population.

Keyphrases

locally advanced
rectal cancer
neoadjuvant chemotherapy
squamous cell carcinoma
radiation therapy
phase ii study
clinical trial
combination therapy
open label